ASTARTE + CELLERO SUCCESS STORY
Leading a vital biotech company through rapid growth to a $38M acquisition.
Stage: Public; Acquired by Charles River Labs (NYSE: CRL) in 2020
Astarte-Cellero Growth Story
The growth journey
Using educational content, SEO, LinkedIn Ads, and email cadences, we launched brand awareness and lead generation campaigns with best-in-class attribution.
"They grew our business by 6x with no sales team!"
Clarity Quest grew our business by 6x in just four years... and we didn't have a sales team! I enjoy the enthusiasm and knowledge of the CQ team and trust them implicitly for all things marketing.
Anne Lodge, Principal | Astarte Biologics/Cellero
In 2018, Astarte merged with Memphis-based Key Biologics, a supplier of leukapheresis products and related collection services. The combined entity selected us to define their go-to-market branding and communication strategy.
"We have an amazing new brand thanks to your leadership."
I just want to express my gratitude for all the work the CQ team put into getting us to launch. We are all very excited about our new brand, and appreciate your team’s leadership and facilitation of brand design and messaging. It is very rewarding to have a unifying brand for our team and our stakeholders to rally around. Thank you!
Jeffrey D. Allen, President & CEO | Cellero
$38 million acquisition
The Cellero brand launch and aggressive expansion plans raised eyebrows across the industry. In 2020, Charles River Laboratories International (NYSE: CRL) acquired Cellero for approximately $38 million in cash.